We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord

Ticker
BSX

Price
101.30
Stock movement down
-0.84 (-0.79%)
Company name
Boston Scientific Corp
Exchange
(NYSE
,
Currency
USD
)
Sector
Healthcare >
Medical Devices
Markedsværdi
155.89B
Ent værdi
170.51B
Pris/omsætning
9.80
Pris/bog
7.44
Udbytte afkast
-
Udbyttevækst
-
Vekst år
-
FCF-udbetaling
2.04%
Efterfølgende P/E
87.14
Fremtidig P/E
30.96
PEG
12.17
EPS-vekst
-1.81%
1 års afkast
33.72%
3 års afkast
35.44%
5 års afkast
21.85%
10 års afkast
19.82%
Senest opdateret: 2025-09-12

iO Charts is a Seeking Alpha partner

UDBYTTE

BSX betaler ikke udbytte

iO Charts is a Seeking Alpha partner

VÆRDIANSÆTTELSE

Værdiansættelsesforhold

Loading...
Værdiansættelsesforhold-data
Efterfølgende P/E87.14
Pris til OCF53.10
Pris til FCF79.34
Pris til EBITDA37.00
EV i forhold til EBITDA40.47

Værdiansættelse (salg/bogført værdi)

Loading...
Værdiansættelse (salg/bogført værdi)-data
Pris til omsætning9.80
Pris til egenkapital7.44
EV i forhold til salg10.72
30. september 2025

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

ØKONOMI

Pr. aktie

Loading...
Data pr. aktie
Aktuelt antal aktier1.48B
EPS (TTM)1.20
FCF pr. aktie (TTM)1.32

Resultatopgørelse

Loading...
Resultatopgørelse-data
Omsætning (TTM)15.91B
Bruttofortjeneste (TTM)10.71B
Driftsindkomst (TTM)2.76B
Nettoindkomst (TTM)1.79B
EPS (TTM)1.20
EPS (1 år frem)3.39

Marginer

Loading...
Marginer-data
Bruttomargin (TTM)67.30%
Driftsmargin (TTM)17.33%
Fortjenstmargin (TTM)11.24%

Balance

Loading...
Opret en gratis konto eller log ind for at få adgang til dette diagram
Balancedata
Kontanter2.50B
Nettotilgodehavender2.50B
Omsætningsaktiver i alt8.76B
Goodwill15.03B
Immaterielle aktiver5.75B
Ejendomme, anlæg og udstyr7.12B
Sum aktiver38.08B
Kreditor907.00M
Kortfristet/nuværende langsigtet gæld11.26B
Summen af kortfristede forpligtelser5.91B
Sum gæld17.12B
Aktionærernes egenkapital20.96B
Materielle nettoaktiver0.00

Likviditet

Loading...
Opret en gratis konto eller log ind for at få adgang til dette diagram
Kontantstrøm-data
Likviditet fra driften (TTM)2.94B
Investeringsudgifter (TTM)971.00M
Fri pengestrøm (TTM)1.97B
Udbetalt udbytte (TTM)40.00M

Finansiel indkomst

Loading...
Opret en gratis konto eller log ind for at få adgang til dette diagram
Data om finansiel indkomst
Egenkapitalafkast8.54%
Afkast af aktiver4.70%
Afkast af investeret kapital5.62%
Kontant afkast af investeret kapital6.17%

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

INFORMATION OM AKTIER

Aktiediagram

Loading...
Aktiekurs-data
Åbning105.83
Daglig høj105.99
Daglig lav104.91
Daglig volumen5.90M
Højeste gennem alle tider106.66
1 års analytiker estimat124.14
Beta0.66
EPS (TTM)1.20
Udbytte pr. aktie-
Ex-div dato-
Næste dato for resultatpræsentation22 Oct 2025

Nedsidepotensial

Loading...
Nedsidepotensial-data
BSXS&P500
Nuværende prisfald fra top notering-2.37%-1.46%
Højeste prisfald-89.15%-56.47%
Højeste efterår dato26 Jul 20129 Mar 2009
Gennemsnitlig fald fra toppen-39.12%-10.99%
Gennemsnitlig tid til nyt højdepunkt29 days12 days
Maks. tid til nyt højdepunkt4361 days1805 days
OPLYSNINGER OM VIRKSOMHEDEN
BSX (Boston Scientific Corp) company logo
Markedsværdi
155.89B
Markedsværdi kategori
Large-cap
Beskrivelse
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates in two segments, MedSurg and Cardiovascular. The company offers devices to diagnose and treat a range of gastrointestinal conditions, such as resolution clips, biliary stent systems, stents and electrocautery enhanced delivery systems, direct visualization systems, digital catheters, and single-use duodenoscopes, as well as endoluminal surgery and infection prevention portfolios; devices to treat urological conditions, including ureteral stents, catheters, baskets, guidewires, urinary and bowel dysfunction, sheaths, balloons, single-use digital flexible ureteroscopes, holmium laser systems, penile implants, artificial urinary sphincter, laser system, and hydrogel systems; and devices to treat neurological movement disorders and manage chronic pain, such as spinal cord stimulator systems, proprietary programming software, radiofrequency ablation, indirect decompression systems, and intraosseous nerve ablation and deep brain stimulation systems. It also provides technologies for diagnosing and treating coronary artery disease and aortic valve conditions; WATCHMAN FLX, a left atrial appendage closure (LAAC) device; and implantable devices that monitor the heart and deliver electricity to treat cardiac abnormalities, such as cardioverter and cardiac resynchronization therapy defibrillators, MRI S-ICD systems, cardiac resynchronization therapy pacemakers, quadripolar LV leads, ICD leads, pacing leads, remote patient management systems, insertable cardiac monitor systems, and remote cardiac monitoring systems. In addition, the company offers diagnosis and treatment of rate and rhythm disorders of the heart; peripheral arterial and venous diseases; and products to diagnose, treat, and ease forms of cancer. The company was incorporated in 1979 and is headquartered in Marlborough, Massachusetts.
Personale
53000
SEC-indsendelser
Adm. direktør
Michael Mahoney
Land
USA
By
Marlborough
Aktietype
Common stock
CCC-status
-
Utbyttefrekvens
-
ARRANGEMENTER OG PRÆSENTATIONER
ArrangementerPræsentationer
Loading...

iO Charts is a Seeking Alpha partner

FORSTÅ FORRETNINGEN
Loading...